Vivan Therapeutics

We are thrilled to announce we are part of the current cohort of the Hub71 program to launch Vivan Therapeutics and our personalized cancer decision support services in the UAE! We look forward to further interactions within the local ecosystem with prospective investors, oncology partners and collaborators! #cancer #innovation #uaelaunch

Dr. Nahuel Villegas and I are thrilled to present "Personalizing Cancer Treatment Recommendations" to the Cancer Patient Lab Wed Feb 12 at noon ET. Please register via the Eventbrite link below. We look forward to sharing how Vivan Therapeutics's TuMatch and the Personal Discovery Process can personalize cancer treatment. We are especially excited to hear feedback from the Cancer Patient lab community that we can use as we continue to improve our offerings. Thank you Brad Power for the invitation. #cancer #cancerhacking #coloncancer #pancreaticcancer

Vivan Therapeutics' TuMatch software leverages a proprietary data set and AI/ML to enable rapid, personalized cancer treatment direction. By integrating advanced computational biology with clinical expertise, TuMatch provides oncologists with personalized insights that empower patients and improve outcomes. To learn more, watch our new TuMatch video here: https://lnkd.in/ePjuZJCW If you or a loved one is battling cancer please reach out to us at patientcare@vivantx.com to find out if we have a personalized treatment recommendation waiting for you. #oncology #personalisedcancertreatment #GIcancer #bowelcancer #AIHealth #digitalhealth #coloncancer #pancreaticcancer #ColorectalCancer #cancer #Precisionmedicine #CancerConcierge #privatecancer #Personalizedcancer #cancerbreakthrough #molecularoncology

Very excited to represent Vivan Therapeutics at the 15th Clinical Biomarkers & Companion Diagnostics Europe Summit in London, 8th – 10th April. I'm looking forward to a jam-packed programme and to the opportunity to showcase our pioneering work and technology in the closing plenary talk! See the full event guide here: https://ter.li/afevwf

Thank you to CTOAM | Cancer Treatment Options & Management for helping spread awareness of our ground-breaking personalised cancer treatment therapeutics. The inventor of our technology, Dr. Ross Cagan, Regius Professor of Precision Medicine at the University of Glasgow discusses the science behind how we effectively match treatments to the unique tumour profile of cancer patients. To find out if we can help you or your loved one on their cancer journey, please reach out to us at info@vivantx.com Watch the full interview here: https://lnkd.in/e3XuGkak #GIcancer #bowelcancer #precisionmedicine #personalisedcancertreatment #oncology

We are thrilled to have been selected as one of the '20 Start-ups & Spinouts' shaping 2025 to join the AI in Health Accelerator Programme! The programme is run by pioneergroup in partnership with Innovate UK, the UK’s innovation agency and the Medical Research Council. Over the next few months, we’ll be working closely with experts to scale our AI- powered in-vitro health tool for personalised colorectal cancer therapeutics. We are grateful to be part of a community dedicated to transforming science into impactful solutions. #colorectalcancer #bowelcancer #AI #oncology #personalisedcancertreatment

It was an excellent day spent with Laura Towart, Nahuel Villegas and the incredible team at Vivan Therapeutics during their end-of-year Team Day at their labs and offices in White City! Since joining the advisory board earlier this year, I’ve been continually impressed by the progress this company has made. Laura has done an outstanding job building a stellar team, and it’s clear that these strategy sessions have become part of the bedrock of the high-performance culture that is needed to excel in this industry! Looking ahead, we hope to launch some informational meetings, both online and in-person, designed to share insights into our breakthrough technologies and innovations. Collaboration will be key, and we’re eager to connect with Pharma companies, Oncologists, and Patients who share our vision. If you’d like to learn more or explore partnership opportunities feel free to send me a private message here on LinkedIn. #VivanTherapeutics #CancerTreatment #PersonalisedTreatment #CancerResearch #Healthcare #TeamDay #Innovation #BreakthroughTechnology

Join Vivan Therapeutics in Transforming Cancer Care Are you passionate about improving cancer outcomes and making a real impact? Vivan Therapeutics is leading the way in personalized cancer treatments and novel drug development. Here's how: TuMatch Software: We’re launching a global platform for personalized GI cancer treatment recommendations. In addition to guiding Standard of Care and identifying possible clinical trial matches, we help patients who’ve run out of standard treatment options find new therapeutic possibilities. Expanding to Other Cancers: We're extending TuMatch’s data set to include lung cancer and other types, providing more options for patients worldwide. Innovative Drug Combinations: Vivan’s proprietary Nitamek combo has been independently validated by the Vall d'Hebron Institute of Oncology (VHIO) and outperforms current treatments. Collaborations & Co-Development: We're working with institutions like the The Institute of Cancer Research, Comunicació IDIBELL, and Barts Cancer Institute (Queen Mary University of London) to discover novel therapies, for hard to treat cancers, including #pancreatic & #glioblastoma. Rare Disease Drug Discovery: Our high-throughput animal drug screening platform is identifying potential therapies for rare diseases. #raredisease Help Us Scale Our Impact We’re raising funds as a bridge to our Series A, with backing from Mubadala and the P4 Precision Medicine Fund. We’re expanding into the USA, China, and UAE in 2025. If you're interested in supporting our growth, join our syndicate with a minimum investment of £1,000 (EIS-friendly). Join here: https://lnkd.in/ejitpPtS Support Our Mission Charitably For those who wish to contribute from a charitable angle, please consider donating to our sister organization, the My Personal Therapeutics Foundation: Donate here: https://lnkd.in/esP7QF4J Be part of the Vivan community and help us make a difference in cancer care. #impactinvesting #cancer #cancerinvestment #personalizedcancer #colorectalcancer Bill Liao Oliver Smith Nathan McNally

Can anti-parasitic drugs aid in the fight against cancer? Im pleased to report that Vivan Therapeutics has validated a novel anti-cancer therapeutic combination, independently, and in partnership with the Vall d'Hebron Institute of Oncology (VHIO). In the era of most notable technological advances in medicine, cancer, one of the oldest diseases known by humankind still has no solution, claiming over 10m lives annually. While treatment outcomes have significantly improved for a very few types of cancers over the last decades, most tumour types are still highly deadly. One example is pancreatic cancer. In the 70s’, the 10-years survival rate for pancreatic cancer was around 1%. Today, it is still a daunting 1%. One strong reason behind the lack of effective therapies for this cancer is the occurrence of activating mutations in the oncogene KRAS, a genetic alteration present in nearly 90% of pancreatic tumours. Similarly, clinical outcomes remain extremely poor for other tumour types with highly incidence of KRAS mutations, such as colorectal and lung cancers. For Vivan Therapeutics the mission is clear: to put an end to this historical and global malady by identifying novel cancer treatments. Please see attached for more information #cancer #cancerbreakthrough #colorectalcancer #pancreaticcancer #KRAS